All In Biotech

Drug Trial Radar · NCT06238817

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 241 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

241

Actual

Start

Apr 26, 2024

Primary completion

May 21, 2025

Study completion Oct 17, 2025

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Feb 2, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or are intolerant to, or contraindicated to topical corticosteroid (TCS)s and topical calcineurin inhibitor (TCI)s.

Conditions

  • Atopic Dermatitis

Interventions

  • Ruxolitinib CreamDrug

    Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

  • Vehicle CreamDrug

    Matching vehicle cream applied topically to the affected area as a thin film twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving a ≥75% Improvement in the Eczema Area and Severity Index Score (EASI75) at Week 8Time frame: Baseline; Week 8
  2. Percentage of Participants With Investigator's Global Assessment Treatment Success (IGA-TS) at Week 8Time frame: Baseline; Week 8

Locations

94 sites in 14 countries. Site status is shown where the registry gives one.

  • Lynn Institute of the Ozarks

    Little Rock, Arkansas

  • First Oc Dermatology

    Fountain Valley, California

  • Center For Dermatology Cosmetic and Laser Surgery

    Fremont, California

  • Medderm Associates, Inc

    San Diego, California

  • Encore Medical Research, Llc Hollywood

    Hollywood, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Lane Dermatology and Dermatologic Surgery

    Columbus, Georgia

  • Marietta Dermatology the Skin Cancer Center Marietta

    Marietta, Georgia

  • Arlington Dermatology

    Rolling Meadows, Illinois

  • Northshore University Healthsystem

    Skokie, Illinois

  • Oakland Hills Dermatology Pc

    Auburn Hills, Michigan

  • Revival Research Institute, Llc Troy

    Troy, Michigan

  • Best Skin Research

    Camp Hill, Pennsylvania

  • International Clinical Research Tennessee Llc

    Murfreesboro, Tennessee

  • Center For Clinical Studies Webster

    Houston, Texas

  • Texas Dermatology Research Center

    Plano, Texas

  • Rainey and Finklea Dermatology

    San Antonio, Texas

  • North Sound Dermatology

    Mill Creek, Washington

  • Paratus Clinical Research, Woden

    Phillip, Australia

  • Premier Specialists Pty Ltd

    Kogarah, New South Wales, Australia

  • Australian Clinical Research Network

    Maroubra, New South Wales, Australia

  • Veracity Clinical Research

    Woolloongabba, Queensland, Australia

  • Clinical Trials Sa

    Campbelltown, South Australia, Australia

  • Skin Health Institute Inc.

    Carlton, Victoria, Australia

  • Ulb Hospital Erasme

    Brussels, Belgium

  • Cliniques Universitaires Ucl Saint-Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Antwerpen (Uza)

    Edegem, Belgium

  • Universitair Ziekenhuis Gent (Uz Gent)

    Ghent, Belgium

  • Grand Hopital de Charleroi

    Gilly, Belgium

  • Dermatologie Handelskaai

    Kortrijk, Belgium

  • Mhat Dr. Tota Venkova Ad

    Gabrovo, Bulgaria

  • Medical Center Medconsult Pleven Ood

    Pleven, Bulgaria

  • Ambulatory For Specialized Medical Help - Skin and Venereal Diseases

    Sofia, Bulgaria

  • Dcc 'Alexandrovska', Eood

    Sofia, Bulgaria

  • Medical Center Hera Eood

    Sofia, Bulgaria

  • Diagnostic Consultative Center Xxviii

    Sofia, Bulgaria

  • Medical Center Assoc. Prof. Vasilev

    Sofia, Bulgaria

  • Skincare Studio Dermatology Centre

    St. John's, Canada

  • Dermatology Research Institute Inc.

    Calgary, Alberta, Canada

  • Dr. Chih-Ho Hong Medical Inc.

    Surrey, British Columbia, Canada

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.